115–116 COVID-19 Vaccination Program

Eligible Faculty, Staff, and Students Are Encouraged to Receive COVID-19 and Influenza Vaccines

In accordance with the Ministry of Health and Welfare’s “115–116 COVID-19 Vaccination Program,” faculty, staff, and students who are eligible or in need of vaccination are encouraged to receive COVID-19 and influenza vaccines to reduce the risk of infection and cluster transmission.
Starting October 1, 2026, COVID-19 and influenza vaccination will be offered in two phases. The eligible groups for COVID-19 vaccination are as follows:

Phase 1 (Starting October 1, 2026):
Adults aged 65 and above.
Indigenous people aged 55 and above.
Residents and staff of nursing homes, long-term care facilities, and related institutions.
Pregnant women.
High-risk individuals aged 6 months and above, including those who meet the eligibility criteria for publicly funded influenza vaccination (such as individuals with high-risk chronic diseases, a BMI of 30 or above, rare diseases, or major illnesses), as well as individuals with tuberculosis, disabilities (including attention-deficit/hyperactivity disorder, cerebral palsy, congenital disabilities, developmental or learning disabilities, and spinal cord injuries), mental disorders (including mood disorders and schizophrenia), or dementia.
Healthcare and disease prevention personnel.
Staff of preschools and childcare facilities, as well as home-based childcare providers (babysitters).
Parents or primary caregivers of infants younger than 6 months.
Children aged 6 months to under 6 years who have never received a COVID-19 vaccine.

Phase 2 (Starting November 2, 2026):
Adults aged 50–64 who are not at high risk.